Sfoglia per Autore OKOLICSANYI, STEFANO
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology
2020 Strazzabosco, M; Cortesi, P; Conti, S; Okolicsanyi, S; Rota, M; Ciaccio, A; Cozzolino, P; Fornari, C; Gemma, M; Scalone, L; Cesana, G; Fabris, L; Colledan, M; Fagiuoli, S; Ideo, G; Zavaglia, C; Perricone, G; Munari, L; Mantovani, L; Belli, L
Health related quality of life in chronic liver diseases
2020 Cortesi, P; Conti, S; Scalone, L; Jaffe, A; Ciaccio, A; Okolicsanyi, S; Rota, M; Fabris, L; Colledan, M; Fagiuoli, S; Belli, L; Cesana, G; Strazzabosco, M; Mantovani, L
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2019 Ippolito, D; Querques, G; Pecorelli, A; Talei Franzesi, C; Okolicsanyi, S; Strazzabosco, M; Sironi, S
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine
2018 Conti, S; Cortesi, P; Okolicsanyi, S; Rota, M; Ciaccio, A; Gemma, M; Scalone, L; Cesana, G; Cozzolino, P; Fabris, L; Colledan, M; Fagiuoli, S; Ideo, G; Garcia-Tsao, G; Belli, L; Munari, L; Mantovani, L; Strazzabosco, M
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite.
2018 Fornari, C; Cortesi, P; Conti, S; Okolicsanyi, S; Rota, M; Ciaccio, A; Gemma, M; Scalone, L; Cesana, G; Cozzolino, P; Fabris, L; Colledan, M; Fagiuoli, S; Ideo, G; Garcia-Tsao, G; Belli, L; Munari, L; Mantovani, L; Strazzabosco, M
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center
2018 Garancini, M; Nespoli, S; Romano, F; Uggeri, F; Degrate, L; Okolicsanyi, S; Gianotti, L
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine
2018 Carbone, M; Cristoferi, L; Cortesi, P; Rota, M; Ciaccio, A; Okolicsanyi, S; Gemma, M; Scalone, L; Cesana, G; Fabris, L; Colledan, M; Fagiuoli, S; Ideo, G; Belli, L; Munari, L; Mantovani, L; Strazzabosco, M
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions
2018 Ippolito, D; Querques, G; Okolicsanyi, S; Talei Franzesi, C; Pecorelli, A; Lombardi, S; Orsini, E; Strazzabosco, M; Sironi, S
Difference in health related quality of life of chronic liver diseases and general population
2017 Cortesi, P; Conti, S; Scalone, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Belli, L; Cesana, G; Strazzabosco, M; Mantovani, L
Impact of multidisciplinary team approach to liver tumors: 5-Years experience
2017 Okolicsanyi, S; Pontecorvi, V; Bonato, G; Ciaccio, A; Perego, R; Romano, F; Uggeri, F; Leni, D; Vacirca, F; Gambini, A; Mariani, C; Ratti, M; Acquati, M; Zucchini, N; Bovo, G; Corso, R; Strazzabosco, M
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis
2017 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Conti, S; Okolicsanyi, S; Rota, M; Cesana, G; Mantovani, L; Annoni, G; Strazzabosco, M
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
2017 Zavaglia, C; Okolicsanyi, S; Cesarini, L; Mazzarelli, C; Pontecorvi, V; Ciaccio, A; Strazzabosco, M; Belli, L
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study
2017 Ippolito, D; Querques, G; Okolicsanyi, S; Franzesi, C; Strazzabosco, M; Sironi, S
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience
2017 Okolicsanyi, S; Pontecorvi, V; Bonato, G; Ciaccio, A; Perego, R; Romano, F; Uggeri, F; Leni, D; Vacirca, F; Gambini, A; Mariani, A; Ratti, M; Acquati, M; Zucchini, N; Bovo, G; Corso, R; Invernizzi, P; Strazzabosco, M
Liver-allocation policies for patients affected by HCC in Europe
2016 DE CARLIS, L; Di Sandro, S; Centonze, L; Lauterio, A; Buscemi, V; De Carlis, R; Ferla, F; Sguinzi, R; Okolicsanyi, S; Belli, L; Strazzabosco, M
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options
2015 Cortesi, P; Ciaccio, A; Rota, M; Lim, J; De Salvia, S; Okolicsanyi, S; Vinci, M; Belli, L; Mantovani, L; Strazzabosco, M
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis
2015 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Okolicsanyi, S; Rota, M; Mantovani, L; Annoni, G; Strazzabosco, M
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study
2015 Fabris, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Cortesi, P; Belli, L; Fagiuoli, S; Scalone, L; Cesana, G; Mantovani, L; Strazzabosco, M
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis
2015 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Rota, M; Okolicsanyi, S; Mantovani, L; Annoni, G; Strazzabosco, M
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study
2015 Fabris, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Cortesi, P; Buonocore, M; Gemma, M; Giani, P; Belli, L; Fagiuoli, S; Scalone, L; Valsecchi, M; Mantovani, L; Strazzabosco, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile